对外财务资助

Search documents
深圳市海王生物工程股份有限公司第九届董事局第二十五次会议决议公告
Shang Hai Zheng Quan Bao· 2025-08-14 19:41
Group 1 - The company held the 25th meeting of the 9th Board of Directors on August 14, 2025, where all 9 participating directors voted in favor of the proposals [2][4] - The meeting approved the proposal regarding the transfer of equity in a subsidiary, which will require further approval from the shareholders' meeting [3][5] - The company decided to postpone the shareholders' meeting based on work arrangements, with future notifications to be provided for the meeting [8][9] Group 2 - The Supervisory Board also held a meeting on August 14, 2025, where all 3 participating supervisors voted in favor of the same proposals [13][16] - The proposals from the Supervisory Board will also require approval from the shareholders' meeting [15][19] Group 3 - The company announced a guarantee extension that constitutes external guarantees, with a current guarantee balance of RMB 6.5 million for Guangxi Haiwang [22][32] - The company has a total guarantee balance of approximately RMB 49.76 billion, which is 174.96% of the audited net assets for 2024 [40][32] - The Supervisory Board believes that the guarantee extension will not harm the interests of the company and its shareholders [33] Group 4 - The company provided financial assistance due to a passive formation from the transfer of equity in a subsidiary, with an outstanding loan of RMB 2.7 million owed by Guangxi Haiwang [44][46] - The financial assistance will not affect the company's normal operations and is compliant with relevant regulations [46][54] - The company has provided a total of RMB 336.86 million in financial assistance, which is 11.85% of the audited net assets for 2024 [54][55]